Which has better valuation & earnings, HQL or PTY?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio abrdn Life Sciences Investors N/A N/A N/A N/A N/A Pimco Corporate & Income Opportunity Fund $257.54M 9.71 N/A N/A N/A

Is HQL or PTY more profitable?

Company Net Margins Return on Equity Return on Assets abrdn Life Sciences Investors N/A N/A N/A Pimco Corporate & Income Opportunity Fund N/A N/A N/A

Do analysts rate ETOR or HQL?

eToro Group presently has a consensus target price of $50.20, suggesting a potential upside of 62.41%. Given eToro Group's stronger consensus rating and higher possible upside, research analysts clearly believe eToro Group is more favorable than abrdn Life Sciences Investors. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score eToro Group 0 Sell rating(s) 7 Hold rating(s) 10 Buy rating(s) 0 Strong Buy rating(s) 2.59 abrdn Life Sciences Investors 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has stronger valuation & earnings, ETOR or HQL?

eToro Group has higher revenue and earnings than abrdn Life Sciences Investors. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio eToro Group $11.98B 0.21 $215.70M $2.66 11.62 abrdn Life Sciences Investors N/A N/A N/A N/A N/A

Does the media prefer ETOR or HQL?

In the previous week, eToro Group had 3 more articles in the media than abrdn Life Sciences Investors. MarketBeat recorded 5 mentions for eToro Group and 2 mentions for abrdn Life Sciences Investors. abrdn Life Sciences Investors' average media sentiment score of 0.00 beat eToro Group's score of -0.19 indicating that abrdn Life Sciences Investors is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment eToro Group 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral abrdn Life Sciences Investors 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has preferable earnings & valuation, RVT or HQL?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Royce Small-Cap Trust N/A N/A N/A N/A N/A abrdn Life Sciences Investors N/A N/A N/A N/A N/A

Is RVT or HQL more profitable?

Company Net Margins Return on Equity Return on Assets Royce Small-Cap Trust N/A N/A N/A abrdn Life Sciences Investors N/A N/A N/A

Does the media refer more to RVT or HQL?

In the previous week, Royce Small-Cap Trust had 3 more articles in the media than abrdn Life Sciences Investors. MarketBeat recorded 5 mentions for Royce Small-Cap Trust and 2 mentions for abrdn Life Sciences Investors. Royce Small-Cap Trust's average media sentiment score of 1.74 beat abrdn Life Sciences Investors' score of 0.00 indicating that Royce Small-Cap Trust is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Royce Small-Cap Trust 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive abrdn Life Sciences Investors 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has better valuation & earnings, HQL or TY?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio abrdn Life Sciences Investors N/A N/A N/A N/A N/A Tri Continental N/A N/A N/A N/A N/A

Is HQL or TY more profitable?

Company Net Margins Return on Equity Return on Assets abrdn Life Sciences Investors N/A N/A N/A Tri Continental N/A N/A N/A

Does the media prefer HQL or TY?

In the previous week, Tri Continental had 3 more articles in the media than abrdn Life Sciences Investors. MarketBeat recorded 5 mentions for Tri Continental and 2 mentions for abrdn Life Sciences Investors. Tri Continental's average media sentiment score of 1.75 beat abrdn Life Sciences Investors' score of 0.00 indicating that Tri Continental is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment abrdn Life Sciences Investors 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Tri Continental 4 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Which has preferable earnings & valuation, HQL or NUV?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio abrdn Life Sciences Investors N/A N/A N/A N/A N/A Nuveen Municipal Value Fund N/A N/A N/A N/A N/A

Is HQL or NUV more profitable?

Company Net Margins Return on Equity Return on Assets abrdn Life Sciences Investors N/A N/A N/A Nuveen Municipal Value Fund N/A N/A N/A

abrdn Life Sciences Investors (HQL) Competitors

$21.67 +0.12 (+0.56%)

Closing price 03:59 PM Eastern

Extended Trading

$21.66 -0.01 (-0.03%)

As of 04:10 PM Eastern

Compare

HQL vs. PTY, ETOR, RVT, TY, and NUV

Should you buy abrdn Life Sciences Investors stock or one of its competitors? abrdn Life Sciences Investors's main competitors and comparable companies include Pimco Corporate & Income Opportunity Fund (PTY), eToro Group (ETOR), Royce Small-Cap Trust (RVT), Tri Continental (TY), and Nuveen Municipal Value Fund (NUV). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "capital markets" industry.

How does abrdn Life Sciences Investors compare to Pimco Corporate & Income Opportunity Fund?

abrdn Life Sciences Investors (NYSE:HQL) and Pimco Corporate & Income Opportunity Fund (NYSE:PTY) are both finance companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, earnings, dividends, profitability, valuation, risk, media sentiment and analyst recommendations.

In the previous week, Pimco Corporate & Income Opportunity Fund had 1 more articles in the media than abrdn Life Sciences Investors. MarketBeat recorded 3 mentions for Pimco Corporate & Income Opportunity Fund and 2 mentions for abrdn Life Sciences Investors. Pimco Corporate & Income Opportunity Fund's average media sentiment score of 1.14 beat abrdn Life Sciences Investors' score of 0.00 indicating that Pimco Corporate & Income Opportunity Fund is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
abrdn Life Sciences Investors	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Pimco Corporate & Income Opportunity Fund	2 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

abrdn Life Sciences Investors pays an annual dividend of $2.04 per share and has a dividend yield of 9.4%. Pimco Corporate & Income Opportunity Fund pays an annual dividend of $1.42 per share and has a dividend yield of 12.0%.

32.2% of abrdn Life Sciences Investors shares are held by institutional investors. Comparatively, 10.3% of Pimco Corporate & Income Opportunity Fund shares are held by institutional investors. 10.1% of abrdn Life Sciences Investors shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
abrdn Life Sciences Investors	N/A	N/A	N/A	N/A	N/A
Pimco Corporate & Income Opportunity Fund	$257.54M	9.71	N/A	N/A	N/A

abrdn Life Sciences Investors has a beta of 0.76, meaning that its stock price is 24% less volatile than the broader market. Comparatively, Pimco Corporate & Income Opportunity Fund has a beta of 0.81, meaning that its stock price is 19% less volatile than the broader market.

Company	Net Margins	Return on Equity	Return on Assets
abrdn Life Sciences Investors	N/A	N/A	N/A
Pimco Corporate & Income Opportunity Fund	N/A	N/A	N/A

Summary

Pimco Corporate & Income Opportunity Fund beats abrdn Life Sciences Investors on 5 of the 7 factors compared between the two stocks.

How does abrdn Life Sciences Investors compare to eToro Group?

eToro Group (NASDAQ:ETOR) and abrdn Life Sciences Investors (NYSE:HQL) are both finance companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, earnings, valuation, media sentiment, risk, profitability, analyst recommendations and dividends.

eToro Group presently has a consensus target price of $50.20, suggesting a potential upside of 62.41%. Given eToro Group's stronger consensus rating and higher possible upside, research analysts clearly believe eToro Group is more favorable than abrdn Life Sciences Investors.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
eToro Group	0 Sell rating(s)	7 Hold rating(s)	10 Buy rating(s)	0 Strong Buy rating(s)	2.59
abrdn Life Sciences Investors	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

eToro Group has a net margin of 2.17% compared to abrdn Life Sciences Investors' net margin of 0.00%. eToro Group's return on equity of 20.26% beat abrdn Life Sciences Investors' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
eToro Group	2.17%	20.26%	15.36%
abrdn Life Sciences Investors	N/A	N/A	N/A

eToro Group has a beta of 1.68, indicating that its stock price is 68% more volatile than the broader market. Comparatively, abrdn Life Sciences Investors has a beta of 0.76, indicating that its stock price is 24% less volatile than the broader market.

In the previous week, eToro Group had 3 more articles in the media than abrdn Life Sciences Investors. MarketBeat recorded 5 mentions for eToro Group and 2 mentions for abrdn Life Sciences Investors. abrdn Life Sciences Investors' average media sentiment score of 0.00 beat eToro Group's score of -0.19 indicating that abrdn Life Sciences Investors is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
eToro Group	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
abrdn Life Sciences Investors	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

32.2% of abrdn Life Sciences Investors shares are owned by institutional investors. 10.1% of abrdn Life Sciences Investors shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

eToro Group has higher revenue and earnings than abrdn Life Sciences Investors.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
eToro Group	$11.98B	0.21	$215.70M	$2.66	11.62
abrdn Life Sciences Investors	N/A	N/A	N/A	N/A	N/A

Summary

eToro Group beats abrdn Life Sciences Investors on 9 of the 12 factors compared between the two stocks.

How does abrdn Life Sciences Investors compare to Royce Small-Cap Trust?

Royce Small-Cap Trust (NYSE:RVT) and abrdn Life Sciences Investors (NYSE:HQL) are both finance companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, valuation, dividends, risk, profitability, media sentiment, analyst recommendations and institutional ownership.

Royce Small-Cap Trust pays an annual dividend of $1.44 per share and has a dividend yield of 7.7%. abrdn Life Sciences Investors pays an annual dividend of $2.04 per share and has a dividend yield of 9.4%.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Royce Small-Cap Trust	N/A	N/A	N/A	N/A	N/A
abrdn Life Sciences Investors	N/A	N/A	N/A	N/A	N/A

Royce Small-Cap Trust has a beta of 1.2, meaning that its stock price is 20% more volatile than the broader market. Comparatively, abrdn Life Sciences Investors has a beta of 0.76, meaning that its stock price is 24% less volatile than the broader market.

Company	Net Margins	Return on Equity	Return on Assets
Royce Small-Cap Trust	N/A	N/A	N/A
abrdn Life Sciences Investors	N/A	N/A	N/A

In the previous week, Royce Small-Cap Trust had 3 more articles in the media than abrdn Life Sciences Investors. MarketBeat recorded 5 mentions for Royce Small-Cap Trust and 2 mentions for abrdn Life Sciences Investors. Royce Small-Cap Trust's average media sentiment score of 1.74 beat abrdn Life Sciences Investors' score of 0.00 indicating that Royce Small-Cap Trust is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Royce Small-Cap Trust	3 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
abrdn Life Sciences Investors	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

25.6% of Royce Small-Cap Trust shares are held by institutional investors. Comparatively, 32.2% of abrdn Life Sciences Investors shares are held by institutional investors. 0.1% of Royce Small-Cap Trust shares are held by company insiders. Comparatively, 10.1% of abrdn Life Sciences Investors shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Summary

Royce Small-Cap Trust and abrdn Life Sciences Investors tied by winning 3 of the 6 factors compared between the two stocks.

How does abrdn Life Sciences Investors compare to Tri Continental?

abrdn Life Sciences Investors (NYSE:HQL) and Tri Continental (NYSE:TY) are both small-cap finance companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, dividends, earnings, valuation, institutional ownership, profitability, analyst recommendations and media sentiment.

32.2% of abrdn Life Sciences Investors shares are held by institutional investors. Comparatively, 10.2% of Tri Continental shares are held by institutional investors. 10.1% of abrdn Life Sciences Investors shares are held by insiders. Comparatively, 8.7% of Tri Continental shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

abrdn Life Sciences Investors has a beta of 0.76, indicating that its share price is 24% less volatile than the broader market. Comparatively, Tri Continental has a beta of 0.82, indicating that its share price is 18% less volatile than the broader market.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
abrdn Life Sciences Investors	N/A	N/A	N/A	N/A	N/A
Tri Continental	N/A	N/A	N/A	N/A	N/A

Company	Net Margins	Return on Equity	Return on Assets
abrdn Life Sciences Investors	N/A	N/A	N/A
Tri Continental	N/A	N/A	N/A

abrdn Life Sciences Investors pays an annual dividend of $2.04 per share and has a dividend yield of 9.4%. Tri Continental pays an annual dividend of $1.11 per share and has a dividend yield of 3.1%.

In the previous week, Tri Continental had 3 more articles in the media than abrdn Life Sciences Investors. MarketBeat recorded 5 mentions for Tri Continental and 2 mentions for abrdn Life Sciences Investors. Tri Continental's average media sentiment score of 1.75 beat abrdn Life Sciences Investors' score of 0.00 indicating that Tri Continental is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
abrdn Life Sciences Investors	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Tri Continental	4 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Summary

abrdn Life Sciences Investors and Tri Continental tied by winning 3 of the 6 factors compared between the two stocks.

How does abrdn Life Sciences Investors compare to Nuveen Municipal Value Fund?

abrdn Life Sciences Investors (NYSE:HQL) and Nuveen Municipal Value Fund (NYSE:NUV) are both small-cap finance companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, media sentiment, risk, analyst recommendations, earnings, dividends and profitability.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
abrdn Life Sciences Investors	N/A	N/A	N/A	N/A	N/A
Nuveen Municipal Value Fund	N/A	N/A	N/A	N/A	N/A

abrdn Life Sciences Investors has a beta of 0.76, indicating that its stock price is 24% less volatile than the broader market. Comparatively, Nuveen Municipal Value Fund has a beta of 0.38, indicating that its stock price is 62% less volatile than the broader market.

32.2% of abrdn Life Sciences Investors shares are held by institutional investors. Comparatively, 22.5% of Nuveen Municipal Value Fund shares are held by institutional investors. 10.1% of abrdn Life Sciences Investors shares are held by company insiders. Comparatively, 1.0% of Nuveen Municipal Value Fund shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Company	Net Margins	Return on Equity	Return on Assets
abrdn Life Sciences Investors	N/A	N/A	N/A
Nuveen Municipal Value Fund	N/A	N/A	N/A

In the previous week, Nuveen Municipal Value Fund had 1 more articles in the media than abrdn Life Sciences Investors. MarketBeat recorded 3 mentions for Nuveen Municipal Value Fund and 2 mentions for abrdn Life Sciences Investors. Nuveen Municipal Value Fund's average media sentiment score of 1.83 beat abrdn Life Sciences Investors' score of 0.00 indicating that Nuveen Municipal Value Fund is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
abrdn Life Sciences Investors	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Nuveen Municipal Value Fund	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

abrdn Life Sciences Investors pays an annual dividend of $2.04 per share and has a dividend yield of 9.4%. Nuveen Municipal Value Fund pays an annual dividend of $0.13 per share and has a dividend yield of 1.4%.

Summary

abrdn Life Sciences Investors beats Nuveen Municipal Value Fund on 4 of the 6 factors compared between the two stocks.

Get abrdn Life Sciences Investors News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HQL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

HQL vs. The Competition

Export

Metric	abrdn Life Sciences Investors	Capital Markets Industry	Finance Sector	NYSE Exchange
Market Cap	$659.02M	$5.74B	$14.06B	$24.24B
Dividend Yield	9.12%	7.39%	5.89%	3.70%
P/E Ratio	N/A	39.07	29.63	30.25
Price / Sales	N/A	1,215.67	514.32	17.47
Price / Cash	N/A	48.31	30.73	19.81
Price / Book	N/A	3.77	2.88	4.91
Net Income	N/A	$417.46M	$1.31B	$1.07B
7 Day Performance	0.06%	0.81%	1.37%	0.68%
1 Month Performance	12.70%	2.36%	2.98%	3.04%
1 Year Performance	59.29%	7.76%	11.66%	15.13%

abrdn Life Sciences Investors Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
HQL abrdn Life Sciences Investors	N/A	$21.67 +0.6%	N/A	+56.2%	$659.02M	N/A	N/A	N/A	Short Interest Increase
PTY Pimco Corporate & Income Opportunity Fund	N/A	$11.71 +0.3%	N/A	-16.4%	$2.48B	$257.54M	N/A	147,000	Positive News
ETOR eToro Group	4.7314 of 5 stars	$28.62 +3.1%	$51.27 +79.1%	-37.6%	$2.37B	$11.98B	10.76	1,520	Analyst Forecast
RVT Royce Small-Cap Trust	N/A	$18.75 +0.1%	N/A	+16.8%	$2.24B	N/A	N/A	50	Positive News Short Interest Increase
TY Tri Continental	N/A	$35.67 +1.3%	N/A	+6.1%	$1.90B	N/A	N/A	N/A	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:HQL) was last updated on 8/25/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

abrdn Life Sciences Investors (HQL) Competitors

HQL vs. PTY, ETOR, RVT, TY, and NUV

How does abrdn Life Sciences Investors compare to Pimco Corporate & Income Opportunity Fund?

Summary

How does abrdn Life Sciences Investors compare to eToro Group?

Summary

How does abrdn Life Sciences Investors compare to Royce Small-Cap Trust?

Summary

How does abrdn Life Sciences Investors compare to Tri Continental?

Summary

How does abrdn Life Sciences Investors compare to Nuveen Municipal Value Fund?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

HQL vs. The Competition

abrdn Life Sciences Investors Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

abrdn Life Sciences Investors (HQL) Competitors

HQL vs. PTY, ETOR, RVT, TY, and NUV

How does abrdn Life Sciences Investors compare to Pimco Corporate & Income Opportunity Fund?

Does the media refer more to HQL or PTY?

Is HQL or PTY a better dividend stock?

Do insiders & institutionals believe in HQL or PTY?

Which has better valuation & earnings, HQL or PTY?

Which has more volatility and risk, HQL or PTY?

Is HQL or PTY more profitable?

Summary

How does abrdn Life Sciences Investors compare to eToro Group?

Do analysts rate ETOR or HQL?

Is ETOR or HQL more profitable?

Which has more volatility & risk, ETOR or HQL?

Does the media prefer ETOR or HQL?

Do insiders & institutionals hold more shares of ETOR or HQL?

Which has stronger valuation & earnings, ETOR or HQL?

Summary

How does abrdn Life Sciences Investors compare to Royce Small-Cap Trust?

Is RVT or HQL a better dividend stock?

Which has preferable earnings & valuation, RVT or HQL?

Which has more volatility & risk, RVT or HQL?

Is RVT or HQL more profitable?

Does the media refer more to RVT or HQL?

Do insiders & institutionals hold more shares of RVT or HQL?

Summary

How does abrdn Life Sciences Investors compare to Tri Continental?

Do institutionals & insiders have more ownership in HQL or TY?

Which has more volatility & risk, HQL or TY?

Which has better valuation & earnings, HQL or TY?

Is HQL or TY more profitable?

Is HQL or TY a better dividend stock?

Does the media prefer HQL or TY?

Summary

How does abrdn Life Sciences Investors compare to Nuveen Municipal Value Fund?

Which has preferable earnings & valuation, HQL or NUV?

Which has more volatility & risk, HQL or NUV?

Do institutionals & insiders have more ownership in HQL or NUV?

Is HQL or NUV more profitable?

Does the media prefer HQL or NUV?

Is HQL or NUV a better dividend stock?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

HQL vs. The Competition

abrdn Life Sciences Investors Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools